Premium
Histrelin acetate: gonadorelin analogue given once a year
Author(s) -
Chaplin Steve,
Persad Raj
Publication year - 2010
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.586
Subject(s) - medicine , prostate cancer , adverse effect , implant , gynecology , cancer , surgery
Histrelin acetate (Vantas) is a gonadorelin analogue implant for the palliative treatment of advanced prostate cancer given once a year. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Mr Raj Persad considers its potential place in treatment. Copyright © 2010 Wiley Interface Ltd.